The neurological aspects of metabolic storage disorders are receiving unprecedented attention in 2026, as clinicians realize that "systemic" health must include the brain and peripheral nervous system. For too long, treatments focused on the heart and kidneys while the neurological burden of the disease continued to progress. New clinical trials are now specifically targeting the small-fiber...